Hemoglobinopathies Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Increasing need of screening for sickle cell disease specifically in newborns is anticipated to drive the growth of Global Hemoglobinopathies Market.
Global Hemoglobinopathies Market is valued at USD 5.74 Billion in 2018 and expected to reach USD 11.08 Billion by 2025 with the CAGR of 9.85% over the forecast period.
A hemoglobinopathy is an inherited blood disorder in which person has an abnormal form of hemoglobin or decreased production of hemoglobin. Globally, hemoglobinopathies is one of the most common inherited diseases and much more common in northern and central Europe including Germany due to immigration. Clear understanding of the genetics and structure of the globin chains and Hb is required during the diagnosis of hemoglobinopathies. The most common hemoglobinopathies include the sickle cell disease (SCD) and thalassemias (alpha- and beta-). Hemoglobinopathies includes a large heterogeneous group of inherited disorders of hemoglobin synthesis that can be sub classified into thalassemia syndromes and structural hemoglobin variants.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=137462&RequestType=Sample
Hemoglobinopathies Market report is segmented on the basis of application, diagnosis, end-user and regional & country level. Based upon application, hemoglobinopathies market is segmented into thalassemia, sickle cell disease (SCD) and others. Based upon diagnosis, hemoglobinopathies market is segmented as hemoglobin isoelectric focusing, hemoglobin electrophoresis, high performance liquid chromatography, genetic testing and hemoglobin solubility test. On the basis of end-user, the market is divided into hospitals, diagnosis laboratories and research laboratories.
The regions covered in this Global Hemoglobinopathies Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Global hemoglobinopathies market is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Hemoglobinopathies Market Report–
Some major key players for Hemoglobinopathies market are Abbott Diagnostic, Bio-Rad Laboratories Inc., Danaher Corporation, Mindray Medical International Ltd., Nexcelom Bioscience LLC., Nihon Kohden Corporation, PerkinElmer Inc., Siemens Healthineers, and Sysmex Corporation and others.
News–
CHOP, Penn Researchers: CRISPR Screening Reveals Signaling Protein with Key Role in Regulating Hemoglobin in Red Blood Cells
On July 19th, 2019; Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease (SCD). Experiments in cultured human cells reveal that blocking the protein reduces the characteristic sickling that distorts the shape of red blood cells and gives the disease its name.
Request for Methodology @ https://brandessenceresearch.biz/Request/Sample?ResearchPostId=137462&RequestType=Methodology
Increasing Cases of Sickle Cell Disorders and Thalassemia Coupled with Increasing Awareness of Healthcare is Expected to Grow the Global Hemoglobinopathies Market.
The hemoglobinopathies market is expected to witness a huge demand immensely from the past few years, mainly due to the increasing cases of the sickle cell diseases (SCD), β–thalassemia, and rising prevalence of blood related disorders among the individuals worldwide. WHO revealed that, around 7 % of the world’s population carries a hemoglobinopathy gene. In addition to this, screening and accurate identification of hemoglobin (Hb) variants have become extremely important in early days to carry out antenatal diagnosis and prevention of Hb disorders by the hemoglobinopathies. According to world health organization (WHO) reported that, nearly 5% of the world population is found with genetic hemoglobin (Hb) disorders and every year more than 42 million carriers and over 12,000 infants’ major and clinically significant hemoglobinopathy. Furthermore, new therapeutic approaches supported by favorable government initiatives from the emerging countries are fostering the growth of global hemoglobinopathies market. However, this approach is specifically required the unidirectional flow, proper training and relatively high cost can turn out to be restraining factor of this market.
North America is Expected to Dominating the Global Hemoglobinopathies Market.
North America is anticipated to dominate the hemoglobinopathies market during the forecast period. Increased immigration of high risk population along with the improved treatment and widespread presence of healthcare infrastructure has contributed to the vast implementation of newborn screening programs in this region. Nearly 70,000 to 100,000 Americans have sickle cell disease. The evolvement of non-sickling disorders, such as β thalassemia and Hb H disease varies across the US is largely required the testing solutions like Hemoglobinopathies. In addition, Asia pacific is exponentially growing region due to the fact that recent advancements in therapeutic approaches attaining the huge interest coupled with the rise in awareness of sickle cell diseases in this region.
Key Benefits for Global Hemoglobinopathies Market Report–
Global market report covers in depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.
Buy this Report @ https://brandessenceresearch.biz/Buy/Create?ResearchPostId=137462&RequestType=Buy&PurchasePlan=SingleUser
Global Hemoglobinopathies Market Segmentation: –
By Application:
Thalassemia
Sickle cell disease (SCD)
Others
By Diagnosis:
Hemoglobin isoelectric focusing
Hemoglobin electrophoresis
High performance liquid chromatography
Genetic testing
Hemoglobin solubility test
By End-User:
Hospitals
Diagnosis laboratories
Research laboratories
By Regional & Country Analysis:
North America
U.S.
Canada
Europe
U.K.
France
Germany
Italy
Asia Pacific
China
Japan
India
Southeast Asia
Latin America
Brazil
Mexico
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Hemoglobinopathies Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Hemoglobinopathies Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Hemoglobinopathies Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis
2.9.1. Market Attractiveness Analysis by Segmentation
2.9.2. Market Attractiveness Analysis by Region
3. Chapter – Global Hemoglobinopathies Market Overview: Quantitative Analysis
4. Chapter – Global Hemoglobinopathies Market Analysis: By Application
5. Chapter – Global Hemoglobinopathies Market Analysis: By Diagnosis
6. Chapter – Global Hemoglobinopathies Market Analysis: By End-User
7. Chapter – Global Hemoglobinopathies Market Analysis: By Manufacturer
9. Chapter – Company Profiles
9.1. Abbott Diagnostic
9.2. Fluke Calibration
9.2.1. Financials
9.2.2. Product portfolio
9.2.3. Hemoglobinopathies Market Revenue (USD Million) and Market Share (%), 2014 – 2018
9.2.4. Hemoglobinopathies Sales Market Share (%), 2014 – 2018
9.2.5. Business strategy
9.2.6. Recent developments
9.3. Abbott Diagnostic
9.4. Bio-Rad Laboratories Inc.
9.5. Danaher Corporation
9.6. Mindray Medical International Ltd.
9.7. Nexcelom Bioscience LLC.
9.8. Nihon Kohden Corporation
9.9. PerkinElmer Inc.
9.10. Siemens Healthineers
9.11. Sysmex Corporation
9.12. others
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at alan@brandessenceresearch.biz
Website: https://brandessenceresearch.biz
Related Report:
Medical Devices Industry Reports 2019
Ethyl Acetate(EA) Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025
Esomeprazole Market Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025
